Shandong Realcan Pharmaceutical Co Ltd (002589) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Shandong Realcan Pharmaceutical Co Ltd (002589) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.60 Million ≈ $-2.28 Million USD) by net assets (CN¥5.45 Billion ≈ $798.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Shandong Realcan Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Shandong Realcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shandong Realcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Realcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002589 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
V-Mart Retail Limited
NSE:VMART
0.007x
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
0.052x
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
0.014x
NICE Information Service Co. Ltd
KQ:030190
-0.030x
Aeon Credit Service Bhd
KLSE:5139
-0.076x
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
0.005x
ZYLOX-TONBRDG.MED.TECH.H1
F:818
N/A
Citic Guoan Wine Co Ltd
SHG:600084
0.005x

Annual Cash Flow Conversion Efficiency for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. View 002589 share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.42 Billion
≈ $793.52 Million
CN¥13.76 Million
≈ $2.01 Million
0.003x -90.99%
2024-12-31 CN¥5.69 Billion
≈ $833.30 Million
CN¥160.44 Million
≈ $23.48 Million
0.028x +92.59%
2023-12-31 CN¥5.64 Billion
≈ $824.87 Million
CN¥82.47 Million
≈ $12.07 Million
0.015x -83.91%
2022-12-31 CN¥5.75 Billion
≈ $841.67 Million
CN¥523.07 Million
≈ $76.54 Million
0.091x +99.01%
2021-12-31 CN¥9.69 Billion
≈ $1.42 Billion
CN¥442.95 Million
≈ $64.82 Million
0.046x +6.19%
2020-12-31 CN¥9.64 Billion
≈ $1.41 Billion
CN¥414.96 Million
≈ $60.72 Million
0.043x -78.93%
2019-12-31 CN¥10.25 Billion
≈ $1.50 Billion
CN¥2.09 Billion
≈ $306.49 Million
0.204x +1245.34%
2018-12-31 CN¥11.31 Billion
≈ $1.65 Billion
CN¥-201.66 Million
≈ $-29.51 Million
-0.018x +92.88%
2017-12-31 CN¥9.67 Billion
≈ $1.42 Billion
CN¥-2.42 Billion
≈ $-354.40 Million
-0.250x -6.78%
2016-12-31 CN¥7.50 Billion
≈ $1.10 Billion
CN¥-1.76 Billion
≈ $-257.40 Million
-0.234x -71.19%
2015-12-31 CN¥3.40 Billion
≈ $498.16 Million
CN¥-466.26 Million
≈ $-68.23 Million
-0.137x -52.79%
2014-12-31 CN¥1.83 Billion
≈ $267.10 Million
CN¥-163.62 Million
≈ $-23.94 Million
-0.090x +46.11%
2013-12-31 CN¥1.65 Billion
≈ $241.45 Million
CN¥-274.46 Million
≈ $-40.16 Million
-0.166x +10.61%
2012-12-31 CN¥916.39 Million
≈ $134.10 Million
CN¥-170.52 Million
≈ $-24.95 Million
-0.186x +67.99%
2011-12-31 CN¥817.11 Million
≈ $119.57 Million
CN¥-475.03 Million
≈ $-69.51 Million
-0.581x -343.92%
2010-12-31 CN¥296.03 Million
≈ $43.32 Million
CN¥70.56 Million
≈ $10.32 Million
0.238x -9.07%
2009-12-31 CN¥234.18 Million
≈ $34.27 Million
CN¥61.38 Million
≈ $8.98 Million
0.262x +158.80%
2008-12-31 CN¥111.89 Million
≈ $16.37 Million
CN¥-49.88 Million
≈ $-7.30 Million
-0.446x --

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution
Market Cap
$709.00 Million
CN¥4.85 Billion CNY
Market Cap Rank
#10623 Global
#2888 in China
Share Price
CN¥3.22
Change (1 day)
+0.94%
52-Week Range
CN¥2.45 - CN¥4.69
All Time High
CN¥17.35
About

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materi… Read more